211 related articles for article (PubMed ID: 1737670)
1. Provocation of supraventricular tachycardias by an intravenous class I antiarrhythmic drug.
Brembilla-Perrot B; Terrier de la Chaise A
Int J Cardiol; 1992 Feb; 34(2):189-98. PubMed ID: 1737670
[TBL] [Abstract][Full Text] [Related]
2. [Arrhythmogenic effect of ajmaline on the atrial level].
Brembilla-Perrot B; al Ammar A; Terrier de la Chaise A; Cherrier F; Pernot C
Arch Mal Coeur Vaiss; 1989 Dec; 82(12):1983-90. PubMed ID: 2515824
[TBL] [Abstract][Full Text] [Related]
3. Effects of intravenous ajmaline on atrial excitability and conduction in man.
Arribas F; Cosio FG; Palacios J; Alonso M; Lopez-Gil M
Eur Heart J; 1986 Feb; 7(2):158-64. PubMed ID: 3699052
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacology of modern anti-arrhythmia drugs in therapy of supraventricular tachycardia].
Honerjäger P; Schmidt G
Z Gesamte Inn Med; 1993 Sep; 48(9):425-9. PubMed ID: 8212747
[TBL] [Abstract][Full Text] [Related]
5. Proarrhythmic effects of intravenous vasopressors.
Tisdale JE; Patel RV; Webb CR; Borzak S; Zarowitz BJ
Ann Pharmacother; 1995 Mar; 29(3):269-81. PubMed ID: 7606074
[TBL] [Abstract][Full Text] [Related]
6. Paradoxic acceleration of ventricular rate after therapy with lidocaine and ajmaline. Findings in two patients with supraventricular tachyarrhythmia.
Klein HO; Segni ED; Kaplinsky E
Chest; 1977 Apr; 71(4):531-3. PubMed ID: 852326
[TBL] [Abstract][Full Text] [Related]
7. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms.
Katritsis D; Rowland E; O'Nunain S; Shakespeare CF; Poloniecki J; Camm AJ
Eur Heart J; 1995 Dec; 16(12):1930-5. PubMed ID: 8682029
[TBL] [Abstract][Full Text] [Related]
8. Effect of ajmaline on sustained ventricular tachycardia induced by programmed electrical stimulation in conscious dogs after myocardial infarction.
Todt H; Krumpl G; Zojer N; Krejcy K; Raberger G
Naunyn Schmiedebergs Arch Pharmacol; 1993 Sep; 348(3):290-7. PubMed ID: 7694159
[TBL] [Abstract][Full Text] [Related]
9. Clinical types of proarrhythmic response to antiarrhythmic drugs.
Bigger JT; Sahar DI
Am J Cardiol; 1987 Apr; 59(11):2E-9E. PubMed ID: 3554950
[TBL] [Abstract][Full Text] [Related]
10. Sustained symptomatic sinus node reentrant tachycardia: incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents.
Gomes JA; Hariman RJ; Kang PS; Chowdry IH
J Am Coll Cardiol; 1985 Jan; 5(1):45-57. PubMed ID: 3964808
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency catheter ablation in the treatment of supraventricular tachycardia in the elderly.
Epstein LM; Chiesa N; Wong MN; Lee RJ; Griffin JC; Scheinman MM; Lesh MD
J Am Coll Cardiol; 1994 May; 23(6):1356-62. PubMed ID: 8176093
[TBL] [Abstract][Full Text] [Related]
12. Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm.
Crozier IG; Ikram H; Kenealy M; Levy L
Am J Cardiol; 1987 Mar; 59(6):607-9. PubMed ID: 3103410
[TBL] [Abstract][Full Text] [Related]
13. [Electrophysiologic effect of sotalol in supraventricular tachycardias].
Borggrefe M; Breithardt G
Z Kardiol; 1985 Sep; 74(9):506-11. PubMed ID: 4060828
[TBL] [Abstract][Full Text] [Related]
14. Characterization of low right atrial isthmus as the slow conduction zone and pharmacological target in typical atrial flutter.
Tai CT; Chen SA; Chiang CE; Lee SH; Ueng KC; Wen ZC; Huang JL; Chen YJ; Yu WC; Feng AN; Chiou CW; Chang MS
Circulation; 1997 Oct; 96(8):2601-11. PubMed ID: 9355900
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
Fujiki A; Tani M; Mizumaki K; Shimono M; Inoue H
J Cardiovasc Pharmacol; 1994 Mar; 23(3):374-8. PubMed ID: 7515979
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiologic effects of intravenous diltiazem in patients with recurrent supraventricular tachycardias.
Roy D; Marchand E; Chabot M; Gagné P; Waters DD; Bourassa MG
Can J Cardiol; 1985; 1(5):302-5. PubMed ID: 3842093
[TBL] [Abstract][Full Text] [Related]
17. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia].
Kühlkamp V; Mewis C; Mayer F; Seipel L
Z Kardiol; 1990 Oct; 79(10):725-31. PubMed ID: 2087860
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic effects, antiarrhythmic activity and pharmacokinetics of cibenzoline studied with programmed stimulation of the heart in patients with supraventricular reentrant tachycardias.
Waleffe A; Dufour A; Aymard MF; Kulbertus H
Eur Heart J; 1985 Mar; 6(3):253-60. PubMed ID: 4029182
[TBL] [Abstract][Full Text] [Related]
19. [Current treatment of supraventricular tachycardia: drug therapy].
Manz M; Lüderitz B
Z Gesamte Inn Med; 1993 Sep; 48(9):430-8. PubMed ID: 8212748
[TBL] [Abstract][Full Text] [Related]
20. [The pro-arrhythmia effects of anti-arrhythmia agents--theoretical and clinical aspects].
Steinbeck G
Z Kardiol; 1992; 81 Suppl 4():139-43. PubMed ID: 1290290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
